(7.1) mm Hg on oxytocin 50 mU/min (p<0.01). The distension pressure required to induce pain was 24.8 (6.3) mm Hg on placebo, 26 -0 (5.8) on oxytocin 10 mU/min (NS), 33.3 (7.8) mm Hg on oxytocin 20 mU/min (p<0.01), 34.2 (7.6) mm Hg on oxytocin 30 mU/min (p<0.01), and 34.3 (7.9) mm Hg on oxytocin 50 mUl min (p<0.01). Compliance curves were not different after placebo and oxytocin injection at the different doses. Naloxone did not inhibit the effect of oxytocin. Oxytocin also did not alter somatic perception, characterised by the RIII reflex at the level ofthe biceps femori.
Conclusion-Oxytocin significantly increases thresholds for visceral perception in IBS patients at doses equal or to greater than 20 mU/min, possibly by acting at the level ofvisceral afferents.
(Gut 1996; 39: 741-747) Keywords: colonic distension, irritable bowel syndrome, viscerosensitivity, barostat, colonic tone, visceral thresholds, oxytocin.
The pathophysiology of irritable bowel syndrome (IBS) remains largely unknown. A variety of motility disorders have been described but there is no consensus regarding changes in colonic motility under basal conditions,' 2 during emotional stress,3-5 after a meal,' 6 7or in response to pharmacological stimulation. 6 8 It has become apparent that an abnormally decreased threshold for visceral sensitivity may also play an important part in the pathophysiology of IBS. Previous studies in humans have found lowered visceral sensory thresholds during intraluminal distension of the oesophagus in patients with non-cardiac chest pain9 '°and of the stomach in patients with functional dyspepsia." 12 Similar hypersensitivity to distension has also been reported for the colon in IBS patients. '3-'8 Besides opioid peptides, several neuropeptides play an important part as mediators of the antinociceptive pathways: vasopressin, substance P, and neurotensin. '9 It has been recently shown that somatostatin may decrease abdominal symptoms in patients with IBS, increasing visceral sensory thresholds in the colon, up to the level of controls, without modifying pressure-volume relation (compliance).20 It is well known that oxytocin is widely distributed in many areas of the central nervous system and the spinal cord.2' Its effects include both hormonal and neuronal processes. Among the latest, oxytocin may modify behaviour of learning and memory. Oxytocin given intraperitoneally as well as intracisternally to rodents exerts an antinociceptive action. 22 23 In a patient with opiate resistant cancer pain, the injection of oxytocin into the third ventricle was reported to result in effective analgesia.24 25 On the other hand, animal studies have shown that the analgesic effect of oxytocin could be opiate mediated. 22 Consequently the aim of this study was to investigate the effects of oxytocin on thresholds of visceral perception and pain sensation during isobaric colonic distensions in IBS patients, using a computerised barostat and to investigate a possible mediation of these effects by an opioid pathway. In addition, we analysed the effects of an effective dose of oxytocin on somatic perception thresholds, as characterised by the RIII cutaneous reflex.
Methods

PATIENTS
Twenty six patients (15 men) were included. Their mean age was 45 years (range 24-63). All patients had a clinical diagnosis of IBS, based on the Rome criteria26: they presented with abdominal pain at least three times a week and constipation (<3 bowel movements per week). Patients gave informed consent to participate in the experimental procedures that had been approved beforehand by the Institutional Ethical Board.
All patients were required to have a normal physical examination and a normal colonoscopy (to eliminate an organic disease) before acceptance in the study and none were taking medication other than oral contraceptives, at least 15 days before the study. All women were negative for 1-HCG blood test. Patients were admitted to the clinical research unit the day before the study and were prepared by ingesting four litres of polyethyleneglycol 4000. Bowel cleansing was completed by repeated tap water enemas until all faecal effluent was clear fluid, free of any particulate matter. day 0 (DO) at 9 00 am with the patients in the left lateral position using minimal air insufflation. Colonoscopy was performed to the caecum in all patients and no retained particulate matter was observed in any case. Premedication included intravenous propofol (2 mg/kg) (ICI Pharma, Cergy, France), under surveillance of an anaesthetist. A thread attached to the tip of the colonic probes was used to pull it up into the colon alongside the colonoscope (CFV10, Olympus, Tokyo, Japan), by using a biopsy forceps to carry it.
The barostat bag was positioned in the descending colon. Patients were then transported to a recovery room where they were allowed to rest. All experimental procedures began on day 1 (D1) to permit full recovery from anaesthesia. Positions of the colonic probe and barostat bag were verified fluoroscopically before and after experimental procedures. Patients were requested to remain in a 30°supine position during the entire recording sessions.
The barostat bag was used to perform intracolonic isobaric distensions at 8 30 am and 600 pm on day 1 and 830 on day 2 (Fig 1) . Twenty patients received, in a random order, a continuous infusion of placebo (saline solution) or two doses of oxytocin (10 mU/ min: n=8, 20 mU/min: n=16, 30 mU/min: n=12, 50 mU/min: n=4), starting 30 minutes before the distension session began and maintained constant during the whole distension session. Distensions were performed automatically by the computerised barostat to achieve successive increments of 4 mm Hg every five minutes preceded by completely deflating the barostat bag during five minutes before the next distension, until pain threshold was obtained. The average duration of distension experiments on placebo could be estimated at 60 to 70 minutes from the previous studies performed with this distension protocol in our laboratory.'8 20 Using a standardised visceral perception questionnaire, patients were requested to indicate when they first felt an abdominal sensation (threshold of first perception) and then when they first felt a sensation of abdominal pain (threshold of pain). At the pain threshold or when the maximum pressure of 40 mm Hg was reached, the bag was deflated and this completed the experimental procedure.
Effect of naloxon on sensory modulation by oxytocin In six patients, the effect ofnaloxone was tested on the modulation of the sensory thresholds by oxytocin. The barostat bag was used to perform intracolonic isobaric distensions at 8 30 am and 6 30 pm on day 1, according to the same protocol as described above (Fig 1) . Each patient received a continuous infusion of oxytocin (30 mU/min), starting at 8 00 am and 6 00 pm -that is, 30 The influence of treatment on the sensory perception of colonic distension was also evaluated by comparing the number of subjects in whom a sensation was elicited at a certain level of distension. The cumulative number of patients taking placebo and the various doses of oxytocin were compared by the x2 test, with Bonferroni's correction, for each step of distension.
Although the treatment sequences were carefully randomised between subjects, we further tested the possibility of a carry over effect of repeated distensions, using a fully factorial (m)ANOVA to test the influence of order of distension, treatment, and interaction of both on the sensory thresholds. All p values <0 05 were considered significant in this study.
Results
TOLERANCE OF THE PROBE AND TECHNICAL ASPECTS OF RECORDING SESSIONS
A total of 26 patients were included in this study. Placements of probes under colonoscopy was not responsible for any complication. In each patient, the duration of the experiments including distensions never exceeded a 36 hour recording. The probe was well tolerated in all patients: diarrhoea, urgent bowel movement or probe migration did not occur. At the end of the recording session, the position of the probe was checked on a plain film of the abdomen. The tip of the probe was still in the descending colon in all patients. at the dose of 20 mU/min displayed a significant shift towards higher distension pressures when compared with placebo. Furthermore, from 10 to 30 mU/min. However, during barostat bag distension up to the pressure of intravenous infusion of oxytocin at the dose of 32 mm Hg was possible without inducing a 50 mU/min, four patients experienced moder-pain sensation in six IBS patients after ate headache. This is the reason why this group oxytocin (20 mU/min) compared with none of patients was limited to four.
after placebo (p<0.00 1). Pressure (mm Hg) 20 31 32 This finding leads to the conclusion that oxytocin could act directly on the nerve afferent pathways to modulate sensory thresholds. In contrast, changes in compliance have been observed with granisetron, a 5HT-3 antagonist acting on sensory thresholds and also on gut compliance and colonic transit.33 34 The effects of oxytocin on gut motility have been poorly investigated so far. In rats, oxytocin does not delay gastric emptying during the lactation period. Oxytocin could thus also act as an analgesic at either the central or peripheral levels to modulate perception of nociceptive sensations. Systemic or intracerebral injection of vasopressin has been reported to produce antinociception in rodents.37 38 Oxytocin given intraperitoneally22 as well as intracisternally22 23 horns, in particular in the substancia gelatinosa (which is involved in the primary processing nociceptive information), and the intermediolateral column (site of origin of preganglionic sympathetic neurones).37 However oxytocin does not seem to have a major role in the nociceptive processes in the lumbosacral spinal cord in the rat. 37 Oxytocin may thus play the part of a general analgesic. Therefore, we evaluated the effects of an infusion of oxytocin on the somatic perception of a cutaneous electrical stimulation. The level of perception was characterised by the RIII reflex of the biceps femoni.
We did not observe any effect of oxytocin in these experimental conditions on somatic perception in IBS patients. Somatic perception is known to be normal in patients with IBS. 42 This finding allows us to assume that oxytocin does not act through a global analgesic effect and that it could even act only on hypersensitive sensory pathways.
Finally we considered the question of the relation between the endogenous opioid system and oxytocin. This relation has been studied in rats: the antinociceptive effect of oxytocin is prevented by naltrexone and oxytocin causes a small but significant increase in the intensity and duration of the antinociceptive effect of morphine.39 However, a minor but still significant part of the antinociceptive effect of oxytocin may be naloxone insensitive.`In mice, the development of acute morphine tolerance and naloxone-precipitated morphine withdrawal symptoms were inhibited by oxytocin after subcutaneous and intracerebroventricular injection. 43 The same effects were seen after central administration of a specific antioxytocin serum.44 In this study, we could not inhibit the effect of oxytocin on colonic sensory thresholds by naloxone, indicating that in IBS patients, oxytocin modulates viscersal hypersensitivity without interacting with enkephalinergic nerves.
In conclusion, oxytocin increases thresholds of visceral sensory perception in IBS patients, through a modulation of the activity of afferent nerve pathways. The exact level of action of oxytocin is not known so far but its action is not related to a global analgesic effect. Oxytocin also does not change colonic compliance and adaptation of the colon to distension. Although a clinical use of oxytocin to treat abdominal pain related to IBS cannot be envisaged, a better understanding of the relation between visceral sensitivity and the hormones acting on the female genital tract could lead to the development of new treatments for IBS patients as shown recently with the report of some clinical benefit of leuprolide in this disorder. 45 46 bowel syndrome.
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